Fluorinated cycloalkyl-derivatised benzoylguanidines and their use as a medicament

Details for Australian Patent Application No. 2003250821 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Kleeman, Heinz-Werner

Agent Watermark

Pub. Number AU-B-2003250821

PCT Number PCT/EP03/05738

PCT Pub. Number WO2003/106410

Priority 102 26 462.7 13.06.02 DE

Filing date 2 June 2003

Wipo publication date 31 December 2003

Acceptance publication date 11 September 2008

International Classifications

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61K 31/10 (2006.01)

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/00 (2006.01) Drugs for disorders of the endocrine system

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/06 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/08 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/02 (2006.01) Drugs for disorders of the nervous system

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 33/00 (2006.01) Antiparasitic agents

A61P 33/02 (2006.01) Antiparasitic agents

Event Publications

16 October 2003 Complete Application Filed

  Priority application(s): 102 26 462.7 13.06.02 DE

26 February 2004 Application Open to Public Inspection

  Published as AU-B-2003250821

22 December 2005 Assignment before Grant

  Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH

11 September 2008 Application Accepted

  Published as AU-B-2003250821

2 October 2008 Corrigenda

  Applications Accepted - Name Index Under the Name Sanofi-Aventis Deutschland GmbH, Application No. 2003250821, Under INID (72), correct the inventor to Kleemann, Heinz-Werner

22 January 2009 Standard Patent Sealed

12 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003250822-COMMUNICATION METHOD AND CORRESPONDING SYSTEM

2003250820-DISTRIBUTING ELEMENT FOR ELECTROLYTE PERCOLATION ELECTROCHEMICAL CELL